Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease
โ Scribed by Roger W. Rodgers; Jess F. Gamble; K. K. Loh; C. C. Shullenberger
- Book ID
- 102666931
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 594 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Seventeen patients with advanced, previously treated Hodgkin's disease received therapy with a combination of streptozotocin 500 mg/m^2^ /day i.v. days 1โ5, CCNU 100 mg/m^2^ orally day 1, adriamycin 45 mg/m^2^ i.v. day 1, and bleomycin 15 mg/m^2^ i.m. days 1 and 8 at 28โday intervals (S
Since the introduction of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, children with Hodgkin's disease (HD) have been treated with chemotherapy alone. The occurrence of side effects related to irradiation (especially secondary solid tumors) is less likely to occur.